Cholinergic dysfunction in Shy-Drager syndrome: Effect of the parasympathomimetic agent, bethanechol

Research output: Contribution to journalArticle

Abstract

To determine the frequency, severity and organ distribution of cholinergic dysfunction in the Shy-Drager syndrome, eleven patients were prospectively studied. In addition to documenting adrenergic insufficiency, a battery of twelve tests was employed to assess cholinergic function. Six tests demonstrated pupillary, lacrimal, salivary, urinary bladder, sexual and sudomotor dysfunction in the majority of patients. Cardiac vagal function as studied by the heart rate response to deep breathing, the Valsalva manoeuvre, cold face test, apnoeic facial immersion and atropine test was affected in all patients. Oesophageal motility was abnormal in six patients. Cholinergic dysfunction in patients with the Shy-Drager syndrome was widespread but of variable severity and distribution. Subcutaneous administration of the parasympathomimetic agent bethanechol demonstrated hyperresponsiveness of lacrimal, salivary, oesophageal, bowel, bladder and sudomotor functions. It is suggested that the Shy-Drager syndrome is primarily a preganglionic cholinergic disorder with transsynaptic degeneration accounting for the development of postganglionic cholinergic as well as adrenergic dysfunction.

Original languageEnglish (US)
Pages (from-to)5-13
Number of pages9
JournalClinical Autonomic Research
Volume4
Issue number1-2
DOIs
StatePublished - Apr 1 1994
Externally publishedYes

Fingerprint

Parasympathomimetics
Shy-Drager Syndrome
Bethanechol
Cholinergic Agents
Tears
Adrenergic Agents
Urinary Bladder
Valsalva Maneuver
Immersion
Atropine
Respiration
Heart Rate

Keywords

  • Bethanechol chloride
  • Cholinergic dysfunction
  • Shy-Drager syndrome

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Cholinergic dysfunction in Shy-Drager syndrome : Effect of the parasympathomimetic agent, bethanechol. / Khurana, Ramesh.

In: Clinical Autonomic Research, Vol. 4, No. 1-2, 01.04.1994, p. 5-13.

Research output: Contribution to journalArticle

@article{a71b6aab7bf848f9bbcc84210301776e,
title = "Cholinergic dysfunction in Shy-Drager syndrome: Effect of the parasympathomimetic agent, bethanechol",
abstract = "To determine the frequency, severity and organ distribution of cholinergic dysfunction in the Shy-Drager syndrome, eleven patients were prospectively studied. In addition to documenting adrenergic insufficiency, a battery of twelve tests was employed to assess cholinergic function. Six tests demonstrated pupillary, lacrimal, salivary, urinary bladder, sexual and sudomotor dysfunction in the majority of patients. Cardiac vagal function as studied by the heart rate response to deep breathing, the Valsalva manoeuvre, cold face test, apnoeic facial immersion and atropine test was affected in all patients. Oesophageal motility was abnormal in six patients. Cholinergic dysfunction in patients with the Shy-Drager syndrome was widespread but of variable severity and distribution. Subcutaneous administration of the parasympathomimetic agent bethanechol demonstrated hyperresponsiveness of lacrimal, salivary, oesophageal, bowel, bladder and sudomotor functions. It is suggested that the Shy-Drager syndrome is primarily a preganglionic cholinergic disorder with transsynaptic degeneration accounting for the development of postganglionic cholinergic as well as adrenergic dysfunction.",
keywords = "Bethanechol chloride, Cholinergic dysfunction, Shy-Drager syndrome",
author = "Ramesh Khurana",
year = "1994",
month = "4",
day = "1",
doi = "10.1007/BF01828832",
language = "English (US)",
volume = "4",
pages = "5--13",
journal = "Clinical Autonomic Research",
issn = "0959-9851",
publisher = "D. Steinkopff-Verlag",
number = "1-2",

}

TY - JOUR

T1 - Cholinergic dysfunction in Shy-Drager syndrome

T2 - Effect of the parasympathomimetic agent, bethanechol

AU - Khurana, Ramesh

PY - 1994/4/1

Y1 - 1994/4/1

N2 - To determine the frequency, severity and organ distribution of cholinergic dysfunction in the Shy-Drager syndrome, eleven patients were prospectively studied. In addition to documenting adrenergic insufficiency, a battery of twelve tests was employed to assess cholinergic function. Six tests demonstrated pupillary, lacrimal, salivary, urinary bladder, sexual and sudomotor dysfunction in the majority of patients. Cardiac vagal function as studied by the heart rate response to deep breathing, the Valsalva manoeuvre, cold face test, apnoeic facial immersion and atropine test was affected in all patients. Oesophageal motility was abnormal in six patients. Cholinergic dysfunction in patients with the Shy-Drager syndrome was widespread but of variable severity and distribution. Subcutaneous administration of the parasympathomimetic agent bethanechol demonstrated hyperresponsiveness of lacrimal, salivary, oesophageal, bowel, bladder and sudomotor functions. It is suggested that the Shy-Drager syndrome is primarily a preganglionic cholinergic disorder with transsynaptic degeneration accounting for the development of postganglionic cholinergic as well as adrenergic dysfunction.

AB - To determine the frequency, severity and organ distribution of cholinergic dysfunction in the Shy-Drager syndrome, eleven patients were prospectively studied. In addition to documenting adrenergic insufficiency, a battery of twelve tests was employed to assess cholinergic function. Six tests demonstrated pupillary, lacrimal, salivary, urinary bladder, sexual and sudomotor dysfunction in the majority of patients. Cardiac vagal function as studied by the heart rate response to deep breathing, the Valsalva manoeuvre, cold face test, apnoeic facial immersion and atropine test was affected in all patients. Oesophageal motility was abnormal in six patients. Cholinergic dysfunction in patients with the Shy-Drager syndrome was widespread but of variable severity and distribution. Subcutaneous administration of the parasympathomimetic agent bethanechol demonstrated hyperresponsiveness of lacrimal, salivary, oesophageal, bowel, bladder and sudomotor functions. It is suggested that the Shy-Drager syndrome is primarily a preganglionic cholinergic disorder with transsynaptic degeneration accounting for the development of postganglionic cholinergic as well as adrenergic dysfunction.

KW - Bethanechol chloride

KW - Cholinergic dysfunction

KW - Shy-Drager syndrome

UR - http://www.scopus.com/inward/record.url?scp=0028304905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028304905&partnerID=8YFLogxK

U2 - 10.1007/BF01828832

DO - 10.1007/BF01828832

M3 - Article

C2 - 7914443

AN - SCOPUS:0028304905

VL - 4

SP - 5

EP - 13

JO - Clinical Autonomic Research

JF - Clinical Autonomic Research

SN - 0959-9851

IS - 1-2

ER -